XF
JAZZ icon

XML Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

XML Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Hold
6,488
– – 0.11% 151
2026
Q1 		$1.23M Buy
6,488
+127
+2% +$22.2K 0.1% 168
2025
Q4 		$1.08M Sell
6,361
-225
-3% -$34.5K 0.09% 167
2025
Q3 		$868K Buy
6,586
+2,660
+68% +$319K 0.07% 189
2025
Q2 		$417K Buy
3,926
+1,210
+45% +$131K 0.04% 262
2025
Q1 		$337K Buy
+2,716
New +$354K 0.03% 273

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

XML Financial's JAZZ Position: Q2 2026 in Review

XML Financial held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 6,488 shares worth $1.56M. The position accounts for 0.11% of the portfolio, ranked #151.

XML Financial first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 648 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • XML Financial held 6,488 shares of Jazz Pharmaceuticals worth $1.56M as of Q2 2026.
  • XML Financial left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.11% of XML Financial's portfolio in Q2 2026, its #151 holding.
  • XML Financial first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 648 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.